Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Long-term Depression01:05

Long-term Depression

33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Potentiation01:35

Long-term Potentiation

58.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
58.8K
Long-term Potentiation01:25

Long-term Potentiation

3.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
3.7K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.1K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.1K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of age-related neurocognitive disorders by Ginkgo biloba extract: neuroprotection in focus.

International journal of psychiatry in clinical practice·2026
Same author

Capacity to give informed consent in patients with severe mental disorder in different treatment settings.

Frontiers in psychiatry·2026
Same author

Feasibility and efficacy of short cognitive remediation interventions for schizophrenia: a randomized active control trial.

Psychiatry research·2025
Same author

History of miscarriage and postpartum depression: a systematic review and meta-analysis of observational studies.

Journal of psychiatric research·2025
Same author

Disassembling infra-low-frequency neurofeedback: A neurophysiological investigation of its feedback components.

NeuroImage·2025
Same author

Omics-AD-A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics.

Journal of Alzheimer's disease : JAD·2025
Same journal

HER2-mutated lung squamous cell carcinoma responding to trastuzumab deruxtecan followed by pyrotinib: a Case Report.

Frontiers in pharmacology·2026
Same journal

Awareness, attitudes, and self-reported clinical management of antimicrobial-associated neurocognitive adverse effects among healthcare providers in Saudi Arabia.

Frontiers in pharmacology·2026
Same journal

Low-dose dasatinib in second-line therapy or beyond for the treatment of chronic-phase chronic myeloid leukemia: a real-world cohort study.

Frontiers in pharmacology·2026
Same journal

Natural products reshape osteosarcoma cell fate: promoting cell death.

Frontiers in pharmacology·2026
Same journal

<i>Leonurus japonicus</i> Houtt. extract containing isoquercitrin reduces airway inflammation in mice with allergic asthma.

Frontiers in pharmacology·2026
Same journal

Enhancing diabetes treatment by targeted nucleic acid and drug delivery using cell-penetrating peptides, peptide nucleic acids, and receptor targeting.

Frontiers in pharmacology·2026
See all related articles

Related Experiment Video

Updated: Feb 18, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

9.3K

LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.

Rainer Kraehenmann1,2, Dan Pokorny3, Helena Aicher2

  • 1Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zürich, Switzerland.

Frontiers in Pharmacology
|November 24, 2017
PubMed
Summary
This summary is machine-generated.

Lysergic acid diethylamide (LSD) enhances primary process thinking, a mode of cognition typical of altered states, by activating serotonin 2A (5-HT2A) receptors. These effects correlate with subjective experiences like disembodiment and are blocked by ketanserin.

Keywords:
5-HT2A receptorLSDcognitive bizarrenesshealthy subjectsketanserinmental imageryprimary and secondary process thinkingprimary emotions

More Related Videos

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.7K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K

Related Experiment Videos

Last Updated: Feb 18, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

9.3K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.7K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Cognitive Psychology

Background:

  • Serotonin 2A (5-HT2A) receptor stimulation by lysergic acid diethylamide (LSD) is linked to primary process thinking, an implicit cognitive mode common in altered states like dreaming.
  • It remains unclear if LSD induces primary process thinking under controlled conditions and its relation to subjective effects and 5-HT2A receptor activity.

Purpose of the Study:

  • To investigate whether LSD increases primary process thinking in a placebo-controlled setting.
  • To determine if this effect is dependent on 5-HT2A receptor activation.
  • To explore the relationship between primary process thinking and subjective experiences during LSD intoxication.

Main Methods:

  • Twenty-five healthy subjects underwent an audio-recorded mental imagery task under three conditions: placebo, LSD (100 mcg), and LSD with ketanserin (40 mg).
  • Primary index (PI) was measured as the main outcome for primary process thinking.
  • Altered states of consciousness were assessed using the Altered State of Consciousness (5D-ASC) rating scale.

Main Results:

  • LSD significantly increased the primary index compared to placebo (p < 0.001).
  • The increase in primary index correlated positively with subjective experiences of disembodiment and blissful state (p < 0.05).
  • Ketanserin fully blocked LSD-induced increases in primary index and alterations in consciousness.

Conclusions:

  • LSD induces primary process thinking through 5-HT2A receptor activation, associated with disembodiment and blissful states.
  • Primary process thinking plays a key role in organizing subjective experiences during both dreaming and psychedelic states.
  • These findings highlight the neurobiological mechanisms underlying altered states of consciousness induced by psychedelics.